ID

11717

Beskrivning

The purpose of this study is to test the hypothesis that the inhibition of the renin-angiotensin-aldosterone system (RAAS) with the angiotensin receptor blocker valsartan or the renin antagonist aliskiren will improve ventricular hemodynamics, as reflected by a greater reduction in levels of N-terminal proB-type natriuretic peptide (NT-proBNP) compared to placebo in subjects stabilized following acute coronary syndrome (ACS) who are determined to be at high risk due to an elevated concentration of natriuretic peptides. https://clinicaltrials.gov/ct2/show/NCT00409578

Länk

https://clinicaltrials.gov/ct2/show/NCT00409578

Nyckelord

Versioner (1)
  1. 2015-07-28 2015-07-28 -
Uppladdad den

28 juli 2015

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Aliskiren and Valsartan Acute Coronary Syndrome NCT00409578

Engelsk

Eligibility Criteria

1 Formulär  
  1. StudyEvent: ODM
    1. Eligibility Criteria
Inclusion Criteria
Beskrivning

Inclusion Criteria

Male or female outpatients
Beskrivning

Male or female outpatients

Datatyp

boolean

Alias
UMLS CUI-1
C0079399
18 years old or older
Beskrivning

18 years old or older

Datatyp

boolean

Alias
UMLS CUI-1
C0001779
Final diagnosis of acute coronary syndrome
Beskrivning

Final diagnosis of acute coronary syndrome

Datatyp

boolean

Alias
UMLS CUI-1
C0948089
ischemic chest discomfort
Beskrivning

ischemic chest discomfort

Datatyp

boolean

Alias
UMLS CUI-1
C0008031
Elevated concentrations of natriuretic peptide 3-10 days after admission for their qualifying acute coronary syndrome event
Beskrivning

Elevated concentrations of natriuretic peptide 3-10 days after admission for their qualifying acute coronary syndrome event

Datatyp

boolean

Alias
UMLS CUI-1
C1095989
Exclusion criteria
Beskrivning

Exclusion criteria

Presence of clinically overt heart failure
Beskrivning

Presence of clinically overt heart failure

Datatyp

boolean

Alias
UMLS CUI-1
C0018801
Known evidence of left ventricular systolic dysfunction
Beskrivning

Known evidence of left ventricular systolic dysfunction

Datatyp

boolean

Alias
UMLS CUI-1
C1277187
Percutaneous coronary intervention (PCI) less than 24 hours before randomization
Beskrivning

Percutaneous coronary intervention (PCI) less than 24 hours before randomization

Datatyp

boolean

Alias
UMLS CUI-1
C1532338
chronic ACEI therapy
Beskrivning

chronic ACEI therapy

Datatyp

boolean

Alias
UMLS CUI-1
C0003015
chronic ARB therapy
Beskrivning

chronic ARB therapy

Datatyp

boolean

Alias
UMLS CUI-1
C0521942
Tillbaka till toppen

Similar models

Eligibility Criteria

1 Formulär
  1. StudyEvent: ODM
    1. Eligibility Criteria
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Inclusion Criteria
Gender
Item
Male or female outpatients
boolean
C0079399 (UMLS CUI-1)
Age
Item
18 years old or older
boolean
C0001779 (UMLS CUI-1)
Acute coronary syndrome
Item
Final diagnosis of acute coronary syndrome
boolean
C0948089 (UMLS CUI-1)
Chest pain
Item
ischemic chest discomfort
boolean
C0008031 (UMLS CUI-1)
BNP
Item
Elevated concentrations of natriuretic peptide 3-10 days after admission for their qualifying acute coronary syndrome event
boolean
C1095989 (UMLS CUI-1)
Item Group
Exclusion criteria
Heart failure
Item
Presence of clinically overt heart failure
boolean
C0018801 (UMLS CUI-1)
Left ventricular systolic dysfunction
Item
Known evidence of left ventricular systolic dysfunction
boolean
C1277187 (UMLS CUI-1)
PCI
Item
Percutaneous coronary intervention (PCI) less than 24 hours before randomization
boolean
C1532338 (UMLS CUI-1)
ACE inhibitors
Item
chronic ACEI therapy
boolean
C0003015 (UMLS CUI-1)
ARB
Item
chronic ARB therapy
boolean
C0521942 (UMLS CUI-1)
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial